BCL2 and Familial prostate cancer: In addition, clusterin appears to contribute to an anti-apoptotic environment in prostate cancer cells, potentially influencing Bcl-2 activity and leading to increased cell survival, although the direct activation of Bcl-2 by clusterin has not been fully established [44].